IZI Medical Products (IZI) has acquired select soft tissue biopsy and breast localisation needle assets from Cook Medical. The acquired portfolio of products is commercially marketed under the Quick-Core Biopsy Needle, MReye Breast Localisation Coil, and the Kopans and X-Reidy Lesion Localisation Needles.
This represents IZI’s third add-on acquisition in the last 18 months, including another acquisition from Cook in 2017 (the line of Osteo-Site needles).
“IZI is strategically focused in diagnostic and therapeutic areas with imaging modalities, which will allow them to have a closer relationship with the diagnostic and interventional physicians that are performing the procedures,” commented Mark Breedlove, vice president, Vascular Division at Cook Medical. “We were looking for a company that could invest more resources and continue to support these product families, the patients that benefit from them, and the physicians that use them.
“We have worked with IZI in the past and determined that they would be the ideal partner moving forward, and we are pleased to support the transition as IZI prepares to manufacture these products. This agreement will benefit patients, customers, and hospitals alike.”
